Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Retatrutide , a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, has shown weight loss exceeding 24% in clinical trials
GLP3-R Retatrutide - Retatrutide GLP-1/GIP/Glucagon Research Compound GLP3-R Retatrutide Retatrutide GLP-1/GIP/Glucagon Research Compound GLP3-R is a multi-receptor peptide analog studied in Retatrutide-class research involving GLP-1, GIP, and glucagon signaling pathways
10.2337/db11-0227 38 FarrO
phenol, 5.5 mg
US$ 26.58
US$ 28.62
US$ 21.70
US$ 26.58
US$ 21.91
US$ 26.88
US$ 26.32
US$ 21.96
US$ 20.98
US$ 20.29
